In animal studies, the non-quinone HSP90 inhibitor, PU-H71, specifically accumulated in tumors, effectively inhibited the growth of HCC tumors, and was well-tolerated, suggesting a low risk of severe liver toxicity (Breinig et al., 2009). This evidence concerns the gene HSP90AB1 and hepatocellular carcinoma.